These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15932514

  • 1. Leaky phenotype of X-linked agammaglobulinaemia in a Japanese family.
    Kaneko H, Kawamoto N, Asano T, Mabuchi Y, Horikoshi H, Teramoto T, Matsui E, Kondo M, Fukao T, Kasahara K, Kondo N.
    Clin Exp Immunol; 2005 Jun; 140(3):520-3. PubMed ID: 15932514
    [Abstract] [Full Text] [Related]

  • 2. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
    Maekawa K, Yamada M, Okura Y, Sato Y, Yamada Y, Kawamura N, Ariga T.
    Blood Cells Mol Dis; 2010 Apr 15; 44(4):300-4. PubMed ID: 20122858
    [Abstract] [Full Text] [Related]

  • 3. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia.
    Nonoyama S, Tsukada S, Yamadori T, Miyawaki T, Jin YZ, Watanabe C, Morio T, Yata J, Ochs HD.
    J Immunol; 1998 Oct 15; 161(8):3925-9. PubMed ID: 9780159
    [Abstract] [Full Text] [Related]

  • 4. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
    Tao L, Boyd M, Gonye G, Malone B, Schwaber J.
    Hum Mutat; 2000 Dec 15; 16(6):528-9. PubMed ID: 11102984
    [Abstract] [Full Text] [Related]

  • 5. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
    Noordzij JG, de Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, de Groot R, van Dongen JJ.
    Pediatr Res; 2002 Feb 15; 51(2):159-68. PubMed ID: 11809909
    [Abstract] [Full Text] [Related]

  • 6. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T.
    J Allergy Clin Immunol; 2001 Dec 15; 108(6):1012-20. PubMed ID: 11742281
    [Abstract] [Full Text] [Related]

  • 7. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB, Lester T, Levinsky RJ, Kinnon C.
    Clin Exp Immunol; 1998 Feb 15; 111(2):334-8. PubMed ID: 9486400
    [Abstract] [Full Text] [Related]

  • 8. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.
    Lin MT, Chien YH, Shyur SD, Huang LH, Chiang YC, Wen DC, Liang PH, Yang HC.
    Ann Allergy Asthma Immunol; 2006 May 15; 96(5):744-8. PubMed ID: 16729790
    [Abstract] [Full Text] [Related]

  • 9. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
    Wang Y, Kanegane H, Sanal O, Ersoy F, Tezcan I, Futatani T, Tsukada S, Miyawaki T.
    Hum Mutat; 2001 Oct 15; 18(4):356. PubMed ID: 11668622
    [Abstract] [Full Text] [Related]

  • 10. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM, Wang Y, Kanegane H, Futatani T, Pinto J, Vilela MM, Miyawaki T.
    Hum Mutat; 2002 Sep 15; 20(3):235-6. PubMed ID: 12204007
    [Abstract] [Full Text] [Related]

  • 11. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW.
    Eur J Immunol; 1993 Dec 15; 23(12):3109-14. PubMed ID: 8258324
    [Abstract] [Full Text] [Related]

  • 12. Transient myelodysplastic syndrome in X-linked agammaglobulinemia with a novel Btk mutation.
    Narula G, Currimbhoy Z.
    Pediatr Blood Cancer; 2008 Dec 15; 51(6):826-8. PubMed ID: 18726917
    [Abstract] [Full Text] [Related]

  • 13. Genotype/phenotype correlations in X-linked agammaglobulinemia.
    Broides A, Yang W, Conley ME.
    Clin Immunol; 2006 Dec 15; 118(2-3):195-200. PubMed ID: 16297664
    [Abstract] [Full Text] [Related]

  • 14. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
    Pérez de Diego R, López-Granados E, Pozo M, Rodríguez C, Sabina P, Ferreira A, Fontan G, García-Rodríguez MC, Alemany S.
    J Allergy Clin Immunol; 2006 Jun 15; 117(6):1462-9. PubMed ID: 16751014
    [Abstract] [Full Text] [Related]

  • 15. X linked agammaglobulinaemia with a 'leaky' phenotype.
    Jones A, Bradley L, Alterman L, Tarlow M, Thompson R, Kinnon C, Morgan G.
    Arch Dis Child; 1996 Jun 15; 74(6):548-9. PubMed ID: 8758136
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S, Tahiat A, Meddour Y, Chan KW, Chaib S, Benhalla N, Smati L, Bensenouci A, Lau YL, Magdinier F, Djidjik R.
    Clin Immunol; 2015 Dec 15; 161(2):286-90. PubMed ID: 26387629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P, Ritis K, Moschese V, Angelini F, Arvanitidis K, Speletas M, Sideras P, Plebani A, Rossi P.
    Hum Mutat; 2000 Jan 15; 15(1):117. PubMed ID: 10612838
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
    Kristufek D, Aspalter RM, Eibl MM, Wolf HM.
    Mol Immunol; 2007 Mar 15; 44(7):1639-43. PubMed ID: 17045652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.